CompletedNot applicableNCT02157623

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Studying Gorlin syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Edward Maytin, MD, PhD
Principal Investigator: Edward V. Maytin, MD, PhD
The Cleveland Clinic
Intervention: Levulan(drug)
Enrollment: 3 enrolled
Eligibility: All sexes
Timeline: 2016 – 2016

Study locations (1)

Cleveland Clinic, Cleveland, Ohio, United States

Collaborators

DUSA Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02157623 on ClinicalTrials.gov

Other trials for Gorlin syndrome

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE3NCT06050122
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Sol-Gel Technologies, Ltd.

See all trials for Gorlin syndrome →

← Back to all trials